NEW: 🔥 CZ revealed he donated $10 million in $BNB to support Vitalik Buterin’s open-source biotech initiatives. https://t.co/y35xhTZWB6 ...

🔥 JUST IN: CZ says he donated $10M in $BNB to Vitalik’s open-source biotech efforts, calling it “just my little part.” https://t.co/YpoAgJRPie ...

SAN RAFAEL, Calif., July 1, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said today that it completed the previously announced agreement to acquire Inozyme Pharma, Inc. (Nasdaq: INZY) for $4.00 per share in an all-cash transaction worth approximately $270 million. The acquisition will strengthen BioMarin's enzyme therapies portfolio, adding a late-stage enzyme replacement therapy, INZ-701. The medicine is currently being developed for the treatment of ectonucleotide pyrophosphatase/phosp ...

New Alliance Aims to Scale Grocery Logistics for SMEs With Real-Time Tracking, IoT Integration, and Regional Economic ImpactKUALA LUMPUR, Malaysia, July 01, 2025 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a leading e-commerce platform operator, today announced that its subsidiary, Tien Ming Distribution Sdn Bhd (“Tien Ming Distribution”), has entered into a strategic partnership with Taxieco New World Limited (“Taxieco”), a technology-driven logistics soluti ...

Continued Strategic Southeast Retail Growth Positions American Rebel Light Beer as the Leading Patriotic, Better-for-You Beer in the C-Store Channel NASHVILLE, TN, July 01, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), America's Patriotic Brand and creator of American Rebel Light Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self- defense products and apparel, proudly announces addi ...

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 2025年6月27日，加拿大政府以 "国家安全" 为由，命令 海康威视 加拿大有限公司停止在加运营并关闭其业务，这 一行为严重损害了中国企业的合法正当权益，干扰破坏了中加正常经贸合作。6月28日，中国驻加拿大使馆对此表示 强烈不满和坚决反对，强调中国政府一贯鼓励企业按市场原则、国际规则及当地法律开展对外合作，反对泛化国家安 全概念、打压中国企业的错误做法，同时敦促加方停止将经贸问题政治化，为中国企业提供公平环境，中方将采取一 切必要措施维护企业权益。 事件脉络 加拿大政府的行动 加拿大政府以所谓 "国家安全" 为由，要求海康威视加拿大公司停止运营并关闭业务，这一决定延续了部分西方国家 对中国科技企业的打压趋势，且未提供明确的证据支持其指控，本质上是对正常经贸合作的破坏。 中国政府的回应与态度 中国驻加拿大使馆已明确表明立场，强烈反对加方的无理行为，指出其泛化国家安全概念、滥用国家力量歧视打压中 国企业，违背市场原则和国际规则。 中方强调将坚决维护中国企业的正当合法权益，这体现了中国政府对企业海 ...

China wants commercial insurance firms to invest in the development of homegrown medicines, Beijing’s latest bid to support its burgeoning biotech and pharmaceutical sector. https://t.co/OrbM2Dvm0Y ...

截至2025年7月1日 10:53，港股医药ETF(159718)多空胶着，最新报价0.84元。流动性方面，港股医药ETF盘中换手7.06%，成交1753.43万元。拉长时间看， 截至6月30日，港股医药ETF近1年净值上涨63.33%，近1月日均成交1.44亿元。规模方面，港股医药ETF近3月规模增长4966.70万元，实现显著增长。 消息面上，7月1日，国家医保局、国家卫生健康委印发《支持创新药高质量发展的若干措施》，其中提出，推动创新药加快进入定点医药机构。鼓励医保定 点医疗机构于药品目录更新公布后3个月内召开药事会，根据需要及时调整药品配备或设立临时采购绿色通道，保障临床诊疗需求和患者合理用药权益。不 得以医疗机构用药目录数量、药占比等为由影响创新药配备使用。医保目录内谈判药品和商保创新药目录内药品可不受"一品两规"限制。 太平洋证券建议，重视医药板块受市场定价权资金变化所带来的增量影响，尤其是阶段性布局AI医疗及创新药的投资策略：创新药——流动性和风险偏好 提升，数据和BD催化有望成为全年主线。在港股流动性和风险偏好双重提升的背景下，叠加4-6月的AACR、ASCO等会议集中发布数据，创新药biot ...

Core Viewpoint - Shenzhen Jingwang Electronics Co., Ltd. has experienced significant stock price fluctuations, with a cumulative increase exceeding 20% over three consecutive trading days, prompting a warning for investors to exercise caution in their investment decisions [1][2]. Company Overview - The company specializes in the research, development, production, and sales of PCBs (Printed Circuit Boards), including multi-layer boards, thick copper boards, high-frequency and high-speed boards, metal-based circuit boards, double-sided/multi-layer flexible circuit boards, high-density flexible circuit boards, HDI boards, rigid-flex boards, special material PCBs, carrier boards, and packaging substrates [1]. - Its products are widely used in various sectors such as automotive, next-generation communication technology, data centers, AIoT, consumer electronics, industrial interconnect, medical devices, new energy, and satellite communication [1]. Stock Performance - The stock price of the company reached a new high on June 30, 2025, following a significant short-term increase, which has raised concerns about potential investment risks [1]. - The company's recent trading volume has significantly exceeded previous levels, indicating heightened market activity [3]. Shareholder Actions - The controlling shareholder, Jinghong Yongtai Investment Holdings Co., Ltd., along with other related parties, has announced a plan to reduce their holdings by a total of 29.49 million shares, which is up to 3% of the company's total share capital, through both centralized bidding and block trading methods [3][4]. - As of the announcement date, the reduction plan is currently in progress, with a portion of shares already sold in accordance with the disclosed plan [4]. Regulatory Compliance - The company has confirmed that there are no undisclosed matters that should be reported according to the regulations of the Shanghai Stock Exchange [5].

天风证券股份有限公司 关于博通集成电路（上海）股份有限公司 部分募投项目结项及部分募投项目变更、延期 的核查意见 天风证券股份有限公司（以下简称"天风证券"或"保荐机构"）作为博通 集成电路（上海）股份有限公司（以下简称"博通集成"或"公司" ）2020 年度 非公开发行股票的保荐机构，根据《上市公司募集资金监管规则》《上海证券交 易所股票上市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运 作》等有关规定，对公司部分募投项目结项及部分募投项目变更、延期的事项进 行了审慎核查，具体核查情况如下： 一、募集资金基本情况 （一）2019 年首次公开发行股票募集资金情况及项目结项情况 经中国证券监督管理委员会"证监许可2019354 号" 《关于核准博通集成电 路（上海）股份有限公司首次公开发行股票的批复》核准，向社会公开发行人民 币普通股（A 股）股票 34,678,384.00 股，每股发行价格为人民币 18.63 元，募集 资金人民币 646,058,293.92 元，募集资金净额为 603,076,507.38 元。上述资金到 位情况业经立信会计师事务所（特殊普通合伙）验证，并出具信会师报字2 ...